NL
VKTX icon

NVWM LLC’s Viking Therapeutics VKTX Stock Holding History

NVWM LLC’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44K Hold
165
– – ﹤0.01% 339
2026
Q1 		$5.37K Hold
165
– – ﹤0.01% 339
2025
Q4 		$5.8K Buy
+165
New +$5.85K ﹤0.01% 344
2024
Q4 		– Sell
-15,784
Closed -$999K – 700
2024
Q3 		$999K Buy
+15,784
New +$926K 0.25% 127

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

NVWM LLC's VKTX Position: Q2 2026 in Review

NVWM LLC held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 165 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

NVWM LLC first reported a position in VKTX in Q3 2024 and has held it in 4 quarters since. The position peaked at $999K in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • NVWM LLC held 165 shares of Viking Therapeutics worth $6.44K as of Q2 2026.
  • NVWM LLC left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #339 holding.
  • NVWM LLC first reported a position in Viking Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • NVWM LLC's Viking Therapeutics position peaked at $999K in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.